2025 · 1st Quarter (Jan 1 - Mar 31)

INNOVATIVE VACCINE TECHNOLOGIES

Filed by THE LIVINGSTON GROUP, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 10, 2025
Income: $30,000.00
Expenses: Not reported
Registrant: THE LIVINGSTON GROUP, LLC
Client: INNOVATIVE VACCINE TECHNOLOGIES
Filing UUID: d648ec59-94d0-429f-8964-5365f0717722
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

FY2026 appropriations for the development of a synthetic vaccine

BUD · Budget/Appropriations

FY2026 appropriations for the development of a synthetic vaccine

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.